TY - JOUR
T1 - Foreword - Into the third year with COVID-19. Will gut microbiota be shown to play a role?
AU - Venema, Koen
N1 - Funding Information:
Also for the upcoming years I am curious to see how the IF develops. Although there is a lot of discussion about whether IF is the proper metric to look at, it still is something that is used by a lot of researchers to select a journal. At Beneficial Microbes we also do look at other metrics, but for now I am going to focus on the IF for the following point: compliance with Plan S. For those of you that don’t know what Plan S is: ‘Plan S is an initiative for Open Access publishing that was launched in September 2018. The plan is supported by cOAlition S, an international consortium of research funding and performing organisations. Plan S requires that, from 2021, scientific publications that result from research funded by public grants must be published in compliant Open Access journals or platforms.’ Since Beneficial Microbes was originally not set up as a full Open Access (OA) journal – although you could publish open access by paying the OA fee – Wageningen Academic Publishers has decided to move towards Plan S compliance (as a transformative journal). See also the post on www.linkedin. com/showcase/beneficial-microbes/, or the publishers website: www.wageningenacademic.com/bm. Since open access means that all of our papers can be downloaded and read by our readers, it could mean that due to this these papers are also (overall) more cited, and that could again affect the IF.
PY - 2022/2/28
Y1 - 2022/2/28
N2 - The third year with the corona virus daily on our retina has started. We've seen many variants of the virus. All very infectious, some apparently more life-threatening than others. Apparently, because I think it is hard to compare the number of cases during the first waves, when people were not yet vaccinated, to the current omicron wave, where clever people have had several vaccine shots. In some countries already up to 4. No matter what antivaxers say about this, all credible scientific data shows that these shots protect against the virus and although they don't stop you from getting sick, you get less sick. Most people that still end up in hospital are those that refused to get a vaccine, or are somehow compromised, e.g. because of a non-functioning immune system. Yet, still some people that have had their vaccine shots end up in the hospital. And although for antivaxers this is the ultimate proof that vaccines don't work, this of course is rubbish... (I usually use stronger phrases, but this gets printed black on white, if you know what I mean)... It would be pertinent to study why the virus breaks through the immune protection of these unfortunate people. Some believe it may be because of the microbiota. Several studies have shown a role of the gut microbiota composition in disease severity, together with vitamin D, cholesterol and other factors. Last year, it was a hype to write a `review' on gut microbiota and the effect on COVID-19, and also the board of Beneficial Microbes has received several submissions of so-called reviews on the topic. However, all of these were rejected, as they were mere speculations about how the gut microbiota might affect virus infection and diseases severity, without any data whatsoever. However, there are now some good studies out there that have shown that a proper gut microbiota may indeed influence disease severity, recently reviewed (Kim, 2021). And in small studies, certain taxa (like Bifidobacterium adolescentis) and microbial pathways (like carbohydrate metabolism) have been correlated to higher neutralising antibodies against the virus (Ng et al., 2022). Very little cause-and-effect evidence still. However, as I stated last year, it may not be too surprising for the knowledgeable reader that the microbiota plays a role in COVID, as the microbiota plays a role in everything that can be wrong with us! We just need to understand the mechanisms better to be able to make use of the microbiota for better disease outcome and perhaps even treatment.
AB - The third year with the corona virus daily on our retina has started. We've seen many variants of the virus. All very infectious, some apparently more life-threatening than others. Apparently, because I think it is hard to compare the number of cases during the first waves, when people were not yet vaccinated, to the current omicron wave, where clever people have had several vaccine shots. In some countries already up to 4. No matter what antivaxers say about this, all credible scientific data shows that these shots protect against the virus and although they don't stop you from getting sick, you get less sick. Most people that still end up in hospital are those that refused to get a vaccine, or are somehow compromised, e.g. because of a non-functioning immune system. Yet, still some people that have had their vaccine shots end up in the hospital. And although for antivaxers this is the ultimate proof that vaccines don't work, this of course is rubbish... (I usually use stronger phrases, but this gets printed black on white, if you know what I mean)... It would be pertinent to study why the virus breaks through the immune protection of these unfortunate people. Some believe it may be because of the microbiota. Several studies have shown a role of the gut microbiota composition in disease severity, together with vitamin D, cholesterol and other factors. Last year, it was a hype to write a `review' on gut microbiota and the effect on COVID-19, and also the board of Beneficial Microbes has received several submissions of so-called reviews on the topic. However, all of these were rejected, as they were mere speculations about how the gut microbiota might affect virus infection and diseases severity, without any data whatsoever. However, there are now some good studies out there that have shown that a proper gut microbiota may indeed influence disease severity, recently reviewed (Kim, 2021). And in small studies, certain taxa (like Bifidobacterium adolescentis) and microbial pathways (like carbohydrate metabolism) have been correlated to higher neutralising antibodies against the virus (Ng et al., 2022). Very little cause-and-effect evidence still. However, as I stated last year, it may not be too surprising for the knowledgeable reader that the microbiota plays a role in COVID, as the microbiota plays a role in everything that can be wrong with us! We just need to understand the mechanisms better to be able to make use of the microbiota for better disease outcome and perhaps even treatment.
KW - COVID-19
KW - Gastrointestinal Microbiome
KW - Humans
KW - Probiotics/therapeutic use
KW - SARS-CoV-2
U2 - 10.3920/BM2022.x001
DO - 10.3920/BM2022.x001
M3 - Editorial
C2 - 35225169
SN - 1876-2883
VL - 13
SP - 1
EP - 2
JO - Beneficial Microbes
JF - Beneficial Microbes
IS - 1
ER -